Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23243193)

1.

Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.

Magnani JW, Wang N, Nelson KP, Connelly S, Deo R, Rodondi N, Schelbert EB, Garcia ME, Phillips CL, Shlipak MG, Harris TB, Ellinor PT, Benjamin EJ; Health, Aging, and Body Composition Study.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):84-90. doi: 10.1161/CIRCEP.112.975342. Epub 2012 Dec 16.

2.

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block.

Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ.

JAMA. 2009 Jun 24;301(24):2571-7. doi: 10.1001/jama.2009.888.

3.

Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.

Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY.

Eur J Heart Fail. 2013 Apr;15(4):415-24. doi: 10.1093/eurjhf/hft004. Epub 2013 Jan 9.

PMID:
23302606
4.

Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Schnabel RB, Aspelund T, Li G, Sullivan LM, Suchy-Dicey A, Harris TB, Pencina MJ, D'Agostino RB Sr, Levy D, Kannel WB, Wang TJ, Kronmal RA, Wolf PA, Burke GL, Launer LJ, Vasan RS, Psaty BM, Benjamin EJ, Gudnason V, Heckbert SR.

Arch Intern Med. 2010 Nov 22;170(21):1909-17. doi: 10.1001/archinternmed.2010.434.

5.

Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study.

Nielsen JB, Pietersen A, Graff C, Lind B, Struijk JJ, Olesen MS, Haunsø S, Gerds TA, Ellinor PT, Køber L, Svendsen JH, Holst AG.

Heart Rhythm. 2013 Sep;10(9):1249-56. doi: 10.1016/j.hrthm.2013.04.012. Epub 2013 Apr 19.

PMID:
23608590
6.

P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).

Magnani JW, Johnson VM, Sullivan LM, Gorodeski EZ, Schnabel RB, Lubitz SA, Levy D, Ellinor PT, Benjamin EJ.

Am J Cardiol. 2011 Mar 15;107(6):917-921.e1. doi: 10.1016/j.amjcard.2010.10.075. Epub 2011 Jan 20.

7.

Clinical characteristics and outcomes associated with the natural history of early repolarization in a young, biracial cohort followed to middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Ilkhanoff L, Soliman EZ, Prineas RJ, Walsh JA 3rd, Ning H, Liu K, Carr JJ, Jacobs DR Jr, Lloyd-Jones DM.

Circ Arrhythm Electrophysiol. 2014 Jun;7(3):392-9. doi: 10.1161/CIRCEP.113.000874. Epub 2014 Apr 23.

PMID:
24759868
8.

A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.

Potpara TS, Stankovic GR, Beleslin BD, Polovina MM, Marinkovic JM, Ostojic MC, Lip GY.

Chest. 2012 Feb;141(2):339-47. doi: 10.1378/chest.11-0340. Epub 2011 May 26.

PMID:
21622553
9.

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.

Mentz RJ, Chung MJ, Gheorghiade M, Pang PS, Kwasny MJ, Ambrosy AP, Vaduganathan M, O'Connor CM, Swedberg K, Zannad F, Konstam MA, Maggioni AP.

Am Heart J. 2012 Dec;164(6):884-92.e2. doi: 10.1016/j.ahj.2012.09.011. Epub 2012 Oct 29.

PMID:
23194489
10.

Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.

Zakeri R, Chamberlain AM, Roger VL, Redfield MM.

Circulation. 2013 Sep 3;128(10):1085-93. doi: 10.1161/CIRCULATIONAHA.113.001475. Epub 2013 Aug 1. Erratum in: Circulation. 2013 Dec 17;128(24):e465.

11.

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.

Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM.

JAMA. 2011 May 25;305(20):2080-7. doi: 10.1001/jama.2011.659.

12.

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.

McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS; Cardiovascular Research Network PRESERVE Study.

J Am Heart Assoc. 2013 Feb 1;2(1):e005694. doi: 10.1161/JAHA.112.005694.

13.

Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.

Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P.

Am J Cardiol. 2014 Sep 15;114(6):909-13. doi: 10.1016/j.amjcard.2014.05.045.

PMID:
25208562
14.

The QT interval and risk of incident atrial fibrillation.

Mandyam MC, Soliman EZ, Alonso A, Dewland TA, Heckbert SR, Vittinghoff E, Cummings SR, Ellinor PT, Chaitman BR, Stocke K, Applegate WB, Arking DE, Butler J, Loehr LR, Magnani JW, Murphy RA, Satterfield S, Newman AB, Marcus GM.

Heart Rhythm. 2013 Oct;10(10):1562-8. doi: 10.1016/j.hrthm.2013.07.023. Epub 2013 Jul 18.

15.

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ.

Circulation. 2003 Jun 17;107(23):2920-5. Epub 2003 May 27.

16.

Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.

Frasure-Smith N, Lespérance F, Habra M, Talajic M, Khairy P, Dorian P, Roy D; Atrial Fibrillation and Congestive Heart Failure Investigators.

Circulation. 2009 Jul 14;120(2):134-40, 3p following 140. doi: 10.1161/CIRCULATIONAHA.109.851675. Epub 2009 Jun 29.

17.

Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.

Qualls LG, Greiner MA, Eapen ZJ, Fonarow GC, Mills RM, Klaskala W, Hernandez AF, Curtis LH.

Clin Cardiol. 2013 Dec;36(12):757-65. doi: 10.1002/clc.22206. Epub 2013 Oct 1.

PMID:
24114926
18.

Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study.

Nyrnes A, Mathiesen EB, Njølstad I, Wilsgaard T, Løchen ML.

Eur J Prev Cardiol. 2013 Oct;20(5):729-36. doi: 10.1177/2047487312446562. Epub 2012 May 15.

PMID:
22588086
19.

Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D; AF-CHF investigators.

Circ Heart Fail. 2012 Sep 1;5(5):586-93. Epub 2012 Jul 12.

20.

Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population.

Eranti A, Aro AL, Kerola T, Anttonen O, Rissanen HA, Tikkanen JT, Junttila MJ, Kenttä TV, Knekt P, Huikuri HV.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1116-21. doi: 10.1161/CIRCEP.114.001557. Epub 2014 Nov 7.

PMID:
25381332
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk